Sustainability Manager, Nature

At Glaxo Smith Kline, we are looking for an experienced and passionate Sustainability Manager, Nature to join our team. As a leader in the health and wellness industry, we are committed to sustainability and are looking for a professional to help us achieve our goals. The ideal candidate will possess a strong commitment to environmental sustainability, a dedication to preserving nature and a deep understanding of the principles of ecology.The Sustainability Manager, Nature will have a key role in designing, developing and implementing sustainability initiatives that support the preservation of natural resources. This individual will also be actively involved in the development and implementation of strategies that reduce the company’s environmental footprint, while also promoting awareness of sustainability issues.Required Qualifications:• Bachelor's degree in Environmental/Sustainability Studies, Ecology, or related field• Minimum of 5 years of experience working in environmental sustainability or ecological conservation• Proven track record of developing and implementing sustainability initiatives• Excellent communication, organizational, and interpersonal skills• Ability to work independently and as part of a team• Knowledge of environmental regulations, policies, and best practices• Ability to think strategically, problem solve, and collaborateIf you are a dynamic individual with a commitment to environmental sustainability and a passion for nature, we would love to hear from you.

According to JobzMall, the average salary range for a Sustainability Manager, Nature in Durham, NC, USA is $46,000 to $75,000 per year. This salary range may be higher or lower depending on the experience, qualifications, and other factors of the individual.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.